Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04197687 |
Title | TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery |
Recruitment | Recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Mayo Clinic |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |